Hepatalin: the missing link in prediabetes, obesity, and type 2 diabetes

Department of Pharmacology and Therapeutics, Max Rady Faculty of Health Sciences, University of Manitoba, 260 Brodie Center 727 McDermot Avenue, Winnipeg, MB R3E 3P5, Canada

Author Contributions: Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft, and Writing – review & editing.

Lautt is co-founder and Chief Scientific Officer of SciMar Ltd, a Canadian biotechnology company (SciMar.ca), that has developed clinical products based on the hepatalin paradigm.

留言 (0)

沒有登入
gif